FDA to share drug approval packages with foreign regulators

The FDA has launched the Global Reliance Disclosure Program, which allows drug and biologic applicants to share the agency’s minimally redacted approval packages with health authorities outside the U.S. The goal is to allow foreign regulators to rely on the FDA’s reviews instead of conducting duplicate evaluations while retaining their own authority over regulatory decisions. […] The post FDA to share drug approval packages with foreign regulators appeared first on Becker's Hospital R...

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.